Pantoprazole Prophylaxis in ICU Patients with High Severity of Disease: a Post Hoc Analysis of the Placebo-controlled SUP-ICU Trial

Overview

Journal Intensive Care Med

Specialty Critical Care

Date 2019 Mar 14

PMID 30863936

Citations 12

Authors

Soren Marker

Anders Perner

Jorn Wetterslev

Mette Krag

Theis Lange

Matt P Wise

Mark Borthwick

Stepani Bendel

Frederik Keus

Anne Berit Guttormsen

Joerg C Schefold

Morten Hylander Moller

Affiliations

Soon will be listed here.

Abstract

Purpose: In the subgroup of patients with Simplified Acute Physiology Score (SAPS) II > 53 in the Stress Ulcer Prophylaxis in Intensive Care Unit (SUP-ICU) trial, there was interaction (P = 0.049) suggesting increased mortality in patients allocated to pantoprazole as compared with placebo. We aimed to explore this further.

Methods: The SUP-ICU trial allocated acutely admitted adults at risk of gastrointestinal bleeding to pantoprazole vs placebo. In this post hoc study, we repeated all the preplanned analyses of SUP-ICU in patients with baseline SAPS II > 53.

Results: A total of 1140 patients had a complete SAPS II > 53 and were included. At 90 days, 272/579 patients (47%) assigned to pantoprazole had died, as compared with 229/558 patients (41%) assigned to placebo [relative risk 1.13; 95% confidence interval (CI) 1.00-1.29]. This was supported by sensitivity analyses adjusted for risk factors and those in the per-protocol population. When accounting for patients with incomplete SAPS II in two additional analyses, the relative risk was 1.08; 95% CI 0.96-1.22 and 1.10; 95% CI 0.97-1.25. This was also observed for the secondary outcome days alive without life support. There were no differences between the intervention groups in the other secondary outcomes.

Conclusions: In this post hoc analysis of patients with high disease severity included in the SUP-ICU trial, we observed higher 90-day mortality and fewer days alive without life support with pantoprazole vs placebo. Some of this may have been explained by missing SAPS II data, but further research is needed to draw firm conclusions. CLINICALTRIALS.GOV: ClinicalTrials.gov No. NCT02467621.

Citing Articles

Gene Profiling as a Tool for Personalized Stress Ulcer Prophylaxis With Proton Pump Inhibitors in Critically Ill Patients - Recommendations Proposal.

Borilova Linhartova P, Zendulka O, Janosek J, Mlcuchova N, Cvanova M, Danek Z Front Med (Lausanne). 2022; 9:854280.

PMID: 35899207 PMC: 9309431. DOI: 10.3389/fmed.2022.854280.

Comparison of proton pump inhibitors and histamine 2 receptor antagonists for stress ulcer prophylaxis in the intensive care unit.

Song M, Kim S, Boo D, Park C, Yoo S, Yoon H Sci Rep. 2021; 11(1):18467.

PMID: 34531488 PMC: 8446063. DOI: 10.1038/s41598-021-98069-7.

Gastrointestinal failure score in children with traumatic brain injury.

Zhou Y, Lu W, Tang W BMC Pediatr. 2021; 21(1):219.

PMID: 33947372 PMC: 8094472. DOI: 10.1186/s12887-021-02673-5.

The efficacy and safety of acid suppressants for gastrointestinal bleeding prophylaxis in cardiac care unit patients.

Chen C, Liu H, Duan R, Wang F, Duan L J Gastroenterol Hepatol. 2021; 36(8):2131-2140.

PMID: 33586808 PMC: 8451749. DOI: 10.1111/jgh.15432.

Major publications in the critical care pharmacotherapy literature: 2019.

Condeni M, Basting A, Costello P, DePriest A, Eriksson E, Evans H J Crit Care. 2021; 62:197-205.

PMID: 33422810 PMC: 7970328. DOI: 10.1016/j.jcrc.2020.12.018.

References

Holst L, Haase N, Wetterslev J, Wernerman J, Guttormsen A, Karlsson S . Lower versus higher hemoglobin threshold for transfusion in septic shock. N Engl J Med. 2014; 371(15):1381-91. DOI: 10.1056/NEJMoa1406617. View

Sehested T, Gerds T, Fosbol E, Hansen P, Charlot M, Carlson N . Long-term use of proton pump inhibitors, dose-response relationship and associated risk of ischemic stroke and myocardial infarction. J Intern Med. 2017; 283(3):268-281. DOI: 10.1111/joim.12698. View

Cook D, Guyatt G . Prophylaxis against Upper Gastrointestinal Bleeding in Hospitalized Patients. N Engl J Med. 2018; 378(26):2506-2516. DOI: 10.1056/NEJMra1605507. View

Alhazzani W, Alshamsi F, Belley-Cote E, Heels-Ansdell D, Brignardello-Petersen R, Alquraini M . Efficacy and safety of stress ulcer prophylaxis in critically ill patients: a network meta-analysis of randomized trials. Intensive Care Med. 2017; 44(1):1-11. PMC: 5770505. DOI: 10.1007/s00134-017-5005-8. View

Oxman A, Guyatt G . A consumer's guide to subgroup analyses. Ann Intern Med. 1992; 116(1):78-84. DOI: 10.7326/0003-4819-116-1-78. View

Krag M, Perner A, Wetterslev J, Wise M, Borthwick M, Bendel S . Prevalence and outcome of gastrointestinal bleeding and use of acid suppressants in acutely ill adult intensive care patients. Intensive Care Med. 2015; 41(5):833-45. DOI: 10.1007/s00134-015-3725-1. View

Selvanderan S, Summers M, Finnis M, Plummer M, Abdelhamid Y, Anderson M . Pantoprazole or Placebo for Stress Ulcer Prophylaxis (POP-UP): Randomized Double-Blind Exploratory Study. Crit Care Med. 2016; 44(10):1842-50. DOI: 10.1097/CCM.0000000000001819. View

Rhodes A, Evans L, Alhazzani W, Levy M, Antonelli M, Ferrer R . Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med. 2017; 43(3):304-377. DOI: 10.1007/s00134-017-4683-6. View

Krag M, Marker S, Perner A, Wetterslev J, Wise M, Schefold J . Pantoprazole in Patients at Risk for Gastrointestinal Bleeding in the ICU. N Engl J Med. 2018; 379(23):2199-2208. DOI: 10.1056/NEJMoa1714919. View

10.

Le Gall J, Lemeshow S, Saulnier F . A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA. 1993; 270(24):2957-63. DOI: 10.1001/jama.270.24.2957. View

11.

Sedgwick P . Randomised controlled trials: subgroup analyses. BMJ. 2014; 349:g7513. DOI: 10.1136/bmj.g7513. View

12.

Granholm A, Moller M, Krag M, Perner A, Hjortrup P . Predictive Performance of the Simplified Acute Physiology Score (SAPS) II and the Initial Sequential Organ Failure Assessment (SOFA) Score in Acutely Ill Intensive Care Patients: Post-Hoc Analyses of the SUP-ICU Inception Cohort Study. PLoS One. 2016; 11(12):e0168948. PMC: 5179262. DOI: 10.1371/journal.pone.0168948. View

13.

von Elm E, Altman D, Egger M, Pocock S, Gotzsche P, Vandenbroucke J . Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007; 335(7624):806-8. PMC: 2034723. DOI: 10.1136/bmj.39335.541782.AD. View

14.

Cook D, Griffith L, Walter S, Guyatt G, Meade M, Heyland D . The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients. Crit Care. 2001; 5(6):368-75. PMC: 83859. DOI: 10.1186/cc1071. View

15.

Macias W, Nelson D, Williams M, Garg R, Janes J, Sashegyi A . Lack of evidence for qualitative treatment by disease severity interactions in clinical studies of severe sepsis. Crit Care. 2005; 9(6):R607-22. PMC: 1414006. DOI: 10.1186/cc3795. View

16.

Charlot M, Ahlehoff O, Norgaard M, Jorgensen C, Sorensen R, Abildstrom S . Proton-pump inhibitors are associated with increased cardiovascular risk independent of clopidogrel use: a nationwide cohort study. Ann Intern Med. 2010; 153(6):378-86. DOI: 10.7326/0003-4819-153-6-201009210-00005. View

17.

Barkun A, Bardou M . Proton-Pump Inhibitor Prophylaxis in the ICU - Benefits Worth the Risks?. N Engl J Med. 2018; 379(23):2263-2264. DOI: 10.1056/NEJMe1810021. View

18.

MacLaren R, Reynolds P, Allen R . Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit. JAMA Intern Med. 2014; 174(4):564-74. DOI: 10.1001/jamainternmed.2013.14673. View

19.

Alhazzani W, Guyatt G, Alshahrani M, Deane A, Marshall J, Hall R . Withholding Pantoprazole for Stress Ulcer Prophylaxis in Critically Ill Patients: A Pilot Randomized Clinical Trial and Meta-Analysis. Crit Care Med. 2017; 45(7):1121-1129. DOI: 10.1097/CCM.0000000000002461. View

20.

Krag M, Perner A, Wetterslev J, Lange T, Wise M, Borthwick M . Stress ulcer prophylaxis in the intensive care unit trial: detailed statistical analysis plan. Acta Anaesthesiol Scand. 2017; 61(7):859-868. DOI: 10.1111/aas.12917. View